BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 429496)

  • 1. Sodium homeostasis and aldosterone secretion in salt-losing congenital adrenal hyperplasia.
    Keenan BS; Holcombe JH; Kirkland RT; Potts VE; Clayton GW
    J Clin Endocrinol Metab; 1979 Mar; 48(3):430-6. PubMed ID: 429496
    [No Abstract]   [Full Text] [Related]  

  • 2. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia.
    Rösler A; Levine LS; Schneider B; Novogroder M; New MI
    J Clin Endocrinol Metab; 1977 Sep; 45(3):500-12. PubMed ID: 198425
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
    Limal JM; Rappaport R; Bayard F
    J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
    Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
    Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma renin activity and aldosterone concentration in normal subjects and patients with salt-losing type of congenital adrenal hyperplasia during infancy.
    Koshimizu T
    Clin Endocrinol (Oxf); 1979 May; 10(5):515-22. PubMed ID: 225066
    [No Abstract]   [Full Text] [Related]  

  • 6. [Congenital salt-losing adrenal hyperplasia].
    Suwa S
    Nihon Rinsho; 1979; 37(2):380-6. PubMed ID: 439428
    [No Abstract]   [Full Text] [Related]  

  • 7. A new form of congenital adrenal hyperplasia.
    New MI; Peterson RE
    J Clin Endocrinol Metab; 1967 Feb; 27(2):300-5. PubMed ID: 6018580
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Horner JM; Hintz RL; Luetscher JA
    J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009
    [No Abstract]   [Full Text] [Related]  

  • 9. Exchangeable sodium and aldosterone secretion in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Loras B; Haour F; Bertrand J
    Pediatr Res; 1970 Mar; 4(2):145-56. PubMed ID: 5419332
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital adrenal hyperplasia: renin and steroid values during treatment.
    Grant DB; Dillon MJ; Atherden SM; Levinsky RJ
    Eur J Pediatr; 1977 Aug; 126(1-2):86-96. PubMed ID: 902665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity in congenital virilizing adrenal hyperplasia.
    Imai M; Igarashi Y; Sokabe H
    Pediatrics; 1968 May; 41(5):897-904. PubMed ID: 5654837
    [No Abstract]   [Full Text] [Related]  

  • 12. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; Berglind N; Wilson RC; New MI
    J Clin Endocrinol Metab; 2007 Jan; 92(1):137-42. PubMed ID: 17032723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].
    Corvol P; Houde M; Benguigui L; Tonnelier M; Menard J; Milliez P
    Nouv Presse Med; 1977 Sep; 6(29):2569-72. PubMed ID: 909737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia.
    Bartter FC; Henkin RI; Bryan GT
    J Clin Invest; 1968 Aug; 47(8):1742-52. PubMed ID: 4299011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation by corticotropin and cortisol of aldosterone secretion in primary aldosteronism.
    Newton MA; Laragh JH
    Arch Intern Med; 1969 Feb; 123(2):147-51. PubMed ID: 4303267
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transient hypoaldosteronism. A case report].
    Haschke F; Hohenauer L; Parth K; Zimprich H
    Padiatr Padol Suppl; 1977; (5):37-42. PubMed ID: 917575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of 21-OHlase deficient adrenal gland hyperplasia developing the initial symptoms of adrenal hypofunction with a salt-losing tendency at the 5th month of age].
    Nozaki Y; Kato Y; Shimizu S; Oyama K; Amamiya S
    Horumon To Rinsho; 1978 Nov; 26(11):1189-96. PubMed ID: 719924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.